Clinical Trials Details

S1826 (Lymphoma)

A Phase III Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma

Clinical Trial Categories

  • Cancers and Other Neoplasms